Opus Point Partners Management, LLC - MERRIMACK PHARMACEUTICALS IN ownership

MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 139 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q4 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.1%.

Quarter-by-quarter ownership
Opus Point Partners Management, LLC ownership history of MERRIMACK PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2016$753,000
-22.2%
90,000
-26.5%
0.58%
-8.9%
Q4 2015$968,000
+83.3%
122,500
+97.6%
0.64%
+118.8%
Q3 2015$528,000
-40.7%
62,009
-13.9%
0.29%
-58.6%
Q2 2015$890,000
+4.1%
72,0090.0%0.70%
-1.7%
Q1 2015$855,000
+5.0%
72,0090.0%0.72%
-10.9%
Q4 2014$814,00072,0090.80%
Other shareholders
MERRIMACK PHARMACEUTICALS IN shareholders Q4 2015
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 514,853$2,595,0002.23%
GARRISON BRADFORD & ASSOCIATES INC 98,001$494,0000.48%
Catalyst Capital Advisors LLC 380,896$1,920,0000.44%
Knoll Capital Management, LLC 160,585$809,0000.42%
Tekla Capital Management LLC 757,050$3,816,0000.38%
FULLER & THALER ASSET MANAGEMENT, INC. 524,800$2,645,0000.13%
Integre Asset Management, LLC 103,493$522,0000.12%
CAMBRIDGE TRUST CO 220,003$1,109,0000.10%
JAMISON EATON & WOOD INC /NJ 62,782$316,0000.09%
STONERIDGE INVESTMENT PARTNERS LLC 88,304$445,0000.09%
View complete list of MERRIMACK PHARMACEUTICALS IN shareholders